Rosenstein M, Eberlein T J, Rosenberg S A
J Immunol. 1984 Apr;132(4):2117-22.
We have investigated the subpopulations of T cells necessary to mediate the cure of established tumors in two models of successful adoptive immunotherapy. In C57BL/6 mice bearing palpable and disseminated FBL-3 lymphoma, both Lyt-1+ and Lyt-2+ cells played a major role in mediating the regression and permanent cure of mice, whereas in BALB/c mice bearing the Meth A sarcoma the adoptive transfer of Lyt-1+2+ cells played a major role in mediating the regression of tumors and the curing of disease. Identical experiments performed in hybrid (BALB/c X C57BL/6) mice yielded similar results, further supporting our initial observation and indicating that in these two adoptive transfer model systems it is the tumor and not the variable expression of Lyt antigens by the host that determines which T cell subpopulation is required to cure mice of tumors.
我们在两种成功的过继性免疫治疗模型中,研究了介导已建立肿瘤治愈所需的T细胞亚群。在携带可触及且已扩散的FBL-3淋巴瘤的C57BL/6小鼠中,Lyt-1⁺和Lyt-2⁺细胞在介导小鼠肿瘤消退和永久治愈中均发挥主要作用,而在携带Meth A肉瘤的BALB/c小鼠中,Lyt-1⁺2⁺细胞的过继转移在介导肿瘤消退和疾病治愈中发挥主要作用。在杂交(BALB/c×C57BL/6)小鼠中进行的相同实验产生了相似结果,进一步支持了我们最初的观察,并表明在这两种过继转移模型系统中,是肿瘤而非宿主Lyt抗原的可变表达决定了治愈小鼠肿瘤所需的T细胞亚群。